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Physical mapping of the breakpoints of a pericentric inversion of the X chromosome (46,X,inv[X][p21q27]) in a
female patient with mild mental retardation revealed localization of the Xp breakpoint in the IL1RAPL gene at
Xp21.3 and the Xq breakpoint near the SOX3 gene (SRY [sex determining region Y]–box 3) (GenBank accession
number NM_005634) at Xq26.3. Because carrier females with microdeletion in the IL1RAPL gene do not present
any abnormal phenotype, we focused on the Xq breakpoint. However, we were unable to confirm the involvement
of SOX3 in the mental retardation in this female patient. To validate SOX3 as an X-linked mental retardation
(XLMR) gene, we performed mutation analyses in families with XLMR whose causative gene mapped to Xq26-
q27. We show here that the SOX3 gene is involved in a large family in which affected individuals have mental
retardation and growth hormone deficiency. The mutation results in an in-frame duplication of 33 bp encoding
for 11 alanines in a polyalanine tract of the SOX3 gene. The expression pattern during neural and pituitary
development suggests that dysfunction of the SOX3 protein caused by the polyalanine expansion might disturb
transcription pathways and the regulation of genes involved in cellular processes and functions required for cognitive
and pituitary development.
X-linked mental retardation (XLMR) affects ∼1/600
males, with a carrier frequency of 2.4/1,000 in females
(Herbst and Miller 1980), and is often highly hetero-
geneous. It can be classified into (i) specific forms
(MRXS), in which mental retardation is associated with
facial or growth abnormalities and/or metabolic or neu-
romuscular disorders, and (ii) nonspecific forms (MRX),
in which affected patients have no distinctive clinical or
biochemical features (Chelly et al. 2001). Both MRXS
and MRX have been localized to all regions of the X
chromosome (Chiurazzi et al. 2001).
We detected a de novo pericentric inversion of the X
chromosome (46,X,inv[X][p21.3q27.1]) in a female pa-
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tient with mild MRX. She was the second child born to
healthy, unrelated parents. Her elder sister was normal,
and there was no significant family history. She was born
at 41 wk of gestation after a normal pregnancy and
delivery. Birth weight was 3,380 g (25th–50th percen-
tile), length 49 cm (25th percentile), and head circum-
ference 35 cm (150th centile). When the patient was 6
mo old, her mother was concerned about significant hy-
potonia. Developmental milestones were delayed in all
areas. The child did not sit unsupported until 1 year of
age and walked at 3 years of age. Language development
was delayed, and she did not speak until the age of 3
years 6 mo. She had strabismus and was operated on at
5 years of age. Clinical examination at age 10 years 9
mo showed no physical abnormalities. No facial dys-
morphism was noted. Speech was low and hypernasal.
There were no behavioral difficulties. Cognitive assess-
ment showed mild mental retardation (IQ 50–55) char-
acterized by a memory deficit, moderate language delay
with a low vocabulary, and poor reasoning.
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Figure 1 Physical map of the breakpoints of the pericentric inversion of the X chromosome. a, Physical map of the pericentric inversion
46,X,inv(X)(p21.3q27.1). The positions of the two breakpoint areas are indicated by diagonally striped boxes. The markers and STS are indicated
(dashes). Their mapping showed that the IL1RAPL gene was disrupted by the Xp breakpoint near the 6th exon. Moreover, the Xq breakpoint
area (100 kb) was localized 100 kb centromeric from the SOX3 gene. b, Results of in situ hybridization analyses on metaphases of the patient
with pericentric inversion, showing FISH signals obtained on normal and inverted X chromosomes with YAC clones 453B11 and 905E10 (green)
for the Xp and Xq breakpoints, respectively, and with a chromosome-X–alphasatellite probe (red) (Qbiogen). Note the hybridization signals
on the inverted X chromosome on both the Xp and Xq sides, indicating that the two YAC clones spanned the breakpoints.
To fine map the breakpoints, we performed FISH anal-
yses using YAC, BAC, or PAC clones, obtained from the
CEPHYAC library and from theCHORI center, as probes
on metaphase chromosomes from the patient. After hy-
bridization and washing, we detected biotinylated probes
using antibiotin antibodies coupled to fluorescein isothi-
ocyanate and digoxigenin probes using antidigoxigenin
antibodies coupled to rhodamin. Chromosomes were
counterstained with DAPI/antifade. The slides were ob-
served under a Zeiss epifluorescence microscope (Ax-
iophot) connected to the Powergene 810 probe system
(Perspective Scientific International). The locations of
the inversion breakpoints and contigs spanning the
breakpoints are shown in figure 1, as is localization of
genes near the Xp and Xq regions.
FISH analyses showed that the YAC clone 453B11
extended over the Xp and Xq breakpoints (fig. 1a and
1b) and that the Xq breakpoint was located in an area
of 100 kb delimited by the BAC clones RP11-51C14
and RP11-189F12 (fig. 1a). Sequence data of the clones
surrounding the overlapping regions indicated the pres-
ence of the IL1RAPL (IL-1 receptor accessory protein
like) gene (Carrie´ et al. 1999) in the Xp breakpoint. We
performed Southern blot analyses using the full-length
cDNA of IL1RAPL (kindly provided by A. Carrie´), and
no abnormal restriction profile was detected in the fe-
male patient (data not shown). Polymerase chain reac-
tions (PCR) of the IL1RAPL exons revealed that the
YAC clone 453B11 contained only the sixth exon of the
gene. The IL1RAPL gene, composed of 11 exons and
involved in MRX, was disrupted in an intronic region
near the sixth exon.
However, we could not exclude the possibility that an
additional gene, located at the Xq breakpoint, was in-
volved in the mental retardation (MR) of this female
patient, because (i) there is evidence of a lack of mental
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Figure 2 Expansion of polyalanine tract detected in the family with mental retardation and GHD (N3) and deletion in the same polyalanine
tract in family T84. A, Family N3. a, Family pedigree. b, Two percent agarose gel electrophoresis of PCR products corresponding to amplification
of part of SOX3 containing the 33-bp duplication. PCR amplification of SOX3 was performed using 50–100 ng of genomic DNA, 0.5 mM
primers described elsewhere by Xiang et al. (2000), and 2.5 U of Taq polymerase (Promega). The PCR cycles consisted of an initial denaturation
step of 95C for 5 min, followed by 30 cycles of amplification (95C for 1 min, 60C for 1 min, 72C for 1 min) and a final cycle at 72C for
7 min. Fifteen family members, including six affected males, were available for this study who showed cosegregation of the duplication with
the phenotype. c, The resulting amino acid sequence of 711–743dup (33 bp) is indicated in italics. The PCR products were purified by gel
electrophoresis and QIAquick gel extraction kit (QIAGEN) and sequenced by ABI BigDye terminator cycle sequencing chemistry on an ABI377
automated sequencer. B, Family T84. a, Family pedigree. b, Two percent agarose gel electrophoresis of PCR products corresponding to am-
plification of part of SOX3 containing the 27-bp deletion. The deletion was observed for the two affected males, their healthy mother, and
their maternal grandfather. c, The resulting amino acid sequence of 718del27 (27 bp) is indicated in italics.
impairment in carrier females with a microdeletion in
the IL1RAPL gene (des Portes et al. 1998; Carrie´ et al.
1999), (ii) a male patient has been reported with a 1.5-
Mbp deletion of the F9-DXS984 region (that overlaps
our Xq breakpoint) associated with hemophilia and
mental retardation (Rousseau et al. 1991), and (iii) the
SOX3 gene (SRY [sex determining region Y]–box 3
[MIM 313430]) that encodes for a transcription factor
that is highly expressed in the fetal brain (and not in
adult brain) and involved in neural development (Ste-
vanovic et al. 1993; Collignon et al. 1996) was localized
at 100 kb from the Xq breakpoint. No other genes have
been identified in the breakpoint area, according to the
Ensembl database. The SOX3 gene can be submitted to
position-effect phenomena (Kleinjan et al. 1998) caused
by inversion of the X chromosome. Indeed, translocation
breakpoints scattered over 1 Mbp of the SOX9 gene
have been reported to cause campomelic dysplasia (Pfeif-
fer et al. 1999), caused by the removal of regulatory
elements of the expression of SOX9. Abnormalities of
the regulatory regions have also been described for the
SRY gene (McElreavey et al. 1992, 1996), which prob-
ably originates from the SOX3 gene (Collignon et al.
1996). We postulated that inversion could lead to dys-
regulation of the expression of the SOX3 gene.
To investigate the effect of the inversion on the ex-
pression of the SOX3 gene, we performed RT-PCR on
RNA extracted from lymphoblastoid cell lines (LCL) of
the patient. We were unable to detect SOX3 transcripts
in either LCL from the patient or in LCL from normal
controls, thus demonstrating that this gene was not ex-
pressed in LCL. Analysis of X chromosome inactivation
on LCL from the patient, at the AR locus (Xq13), re-
vealed a random inactivation profile (data not shown),
confirming that the gene involved in the patient’s MR
was not expressed in LCL.
The pericentric inversion of the X chromosome in this
female patient physically disrupted the IL1RAPL gene.
However, SOX3 could not be excluded, although we
could not test its expression.
Just as homeodomain genes are known to play crucial
roles in the establishment of cerebral structure, SOX3
has been considered a strong candidate gene for other
cases of XLMR. We screened for mutations in all avail-
able families with MRX overlapping the Xq26-q27 re-
gion collected by the European XLMR consortium (15
unrelated mentally retarded males including two with
XLMR and growth hormone deficiency [GHD] [T19
and N3]) and two Australian families with XLMR and
GHD (one described by Zipf [1977]) by direct sequenc-
ing of PCR products corresponding to the entire coding
region of the SOX3 gene (GenBank accession number
NM_005634).
Families N3 and T19 have already been described clin-
ically by Hamel et al. (1996), Hol et al. (2000) (N3),
and Raynaud et al. (1998) (T19). Briefly, all patients in
family N3 were short and mentally retarded. Clinical
examination demonstrated facial anomalies in some but
not all of the patients. On the average, untreated patients
reached their final height, ranging from 135–159 cm, at
the age of 24–25 years. In all patients examined, be-
havior was considered infantile, and laboratory inves-
tigations demonstrated total GHD. In family T19, the
disease was characterized in males by mental retarda-
tion, short stature, microcephaly, and peculiar face.
Mental retardation was mild to borderline. Height and
head circumference were !2.2 SD in all affected males
and females. Facial anomalies, consisting of general
“coarseness,” highly curved forehead and midface hy-
poplasia, and concave nasal bridge with nasal tip of
normal size, were observed in affected males and
females.
Abnormalities were found in two patients. One in-
frame duplication of 33 bp (711–743 dup) encoding for
an additional 11-alanine tract was found in family N3,
with XLMR and isolated GHD (fig. 2A). This dupli-
cation is predicted to cause expansion of the normal
polyalanine tract (amino acids 234–249) by 15 to 26
alanine residues (figs. 2A and 3). Cosegregation of this
duplication with the disease was confirmed in this large
family (fig. 2A). This mutation was not found in 600
normal X chromosomes or in 197 unrelated FRAXA-
negative mentally retarded patients, and no polymor-
phism in the tract was detected in controls. Furthermore,
one deletion of 27 bp (718del27), consisting of a deletion
of nine alanine residues in the same polyalanine tract,
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Figure 3 Position in the SOX3 gene of the mutations identified
in the MR family with GHD and in family T84. The polymorphic
deletion is indicated in italics.
was observed in two severely mentally retarded boys of
family T84 (figs. 2B and 3). However, it is likely that
this sequence variation corresponded to a rare poly-
morphism because of the detection of this deletion in
the healthy maternal grandfather.
No abnormalities were found in the other families
with MR and GHD (T19 and the two Australian fam-
ilies) in the coding region of SOX3.
Mutations in homeobox genes have been shown to play
a role in the pathogenesis of numerous conditions inman.
Furthermore, seven genes have been described in which
alanine expansions have been shown to cause human dis-
ease: FOXL2 (Crisponi et al. 2001), HOXA13 (Good-
man et al. 2000), HOXD13 (Muragaki et al. 1996),
PABP2 (Brais et al. 1998), RUNX2 (Mundlos et al. 1997),
ZIC2 (Brown et al. 2001), and, recently, ARX (Bienvenu
et al. 2002; Stromme et al. 2002), which is associated
with specific and nonspecific XLMR. It is interesting that
the authors also found both a polyalanine duplication
and a rare polymorphism in the ARX gene due to a
deletion. The function of such extended polyalanine
tracts is not yet known, but it has been suggested that
they suppress transcriptional activity of these proteins
(Han et al. 1993).
SOX3 is a member of the SRY-related HMG box fam-
ily and acts as a transcription factor gene of unknown
function which is highly expressed in the human fetal
brain and spinal cord. This gene is a homolog of the
murine Sox3 gene, which is expressed at high levels in
neuronal tissue during development and is thought to
play a role in neuronal development (Stevanovic et al.
1993; Collignon et al. 1996). Expression analysis using
mouse models has also revealed that Sox3 is expressed
in the developing pituitary gland (Collignon et al. 1996).
Furthermore, functional studies of Sox3 in fish embryos
have shown that increased levels of this gene in the de-
veloping lens and otic placodes cause severe hypoplasia
of these tissues (Koster et al. 2000). This could explain
the phenotype in the affected patients in the family with
the duplication. Solomon et al. (2002) recently showed
increased gene levels at Xq26-27 associated with X-
linked hypopituitarism and variable degrees of mental
retardation due to large duplicated regions in the
Xq26.1-q27.3 region, including the SOX3 gene. More-
over, they postulated that SOX3 might be involved in
hypopituitarism due to overexpression of this gene.
SOX3 is a new gene which we have identified as mu-
tated in XLMR associated with GHD. However, the ab-
sence of mutation of this gene particularly in family T19
suggests genetic heterogeneity of this condition.
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